TORRAY INVESTMENT PARTNERS LLC: AMGEN (AMGN): Quarterly 13F Position History
As of Q2 2026, TORRAY INVESTMENT PARTNERS LLC reported 59,771 shares of AMGEN (AMGN), worth $21.6M and representing 2.9% of its 13F equity book. Quarter-over-quarter share count change: + 5,759 (+10.7%) . The position first appeared in Q3 2017 and has been disclosed across 36 13F-HR filings in Pactolio's tracked window.
- 59,771Shares Held (Latest Filing)
- $21.6MReported Market Value (Latest Filing)
- 2.9%Portfolio Weight (% of 13F Equity Book)
- +5,759Quarter-over-Quarter Share Change
- +$2.6MQuarter-over-Quarter Value Change
- 72,530Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 36 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 59,771 | +5,759 | +10.7% | $21.6M | 2.9% | $362.1 |
| Q1 2026 | 54,012 | 10,635 | -16.5% | $19.0M | 2.8% | $351.9 |
| Q4 2025 | 64,647 | 7,883 | -10.9% | $21.2M | 3.0% | $327.3 |
| Q3 2025 | 72,530 | +2,672 | +3.8% | $20.5M | 2.8% | $282.2 |
| Q2 2025 | 69,858 | +12,539 | +21.9% | $19.5M | 2.8% | $279.2 |
| Q1 2025 | 57,319 | 2,808 | -4.7% | $17.9M | 2.7% | $311.6 |
| Q4 2024 | 60,127 | +47,969 | +394.5% | $15.7M | 2.2% | $260.6 |
| Q3 2024 | 12,158 | 3,099 | -20.3% | $3.9M | 0.5% | $322.2 |
| Q2 2024 | 15,257 | 10,715 | -41.3% | $4.8M | 0.7% | $312.5 |
| Q1 2024 | 25,972 | +12,141 | +87.8% | $4.3M | 0.6% | $165.9 |
| Q4 2023 | 13,831 | 549 | -3.8% | $4.0M | 0.6% | $288.0 |
| Q3 2023 | 14,380 | +531 | +3.8% | $3.9M | 0.7% | $268.8 |
| Q2 2023 | 13,849 | +3,360 | +32.0% | $3.1M | 0.5% | $222.0 |
| Q1 2023 | 10,489 | +761 | +7.8% | $2.5M | 0.5% | $241.8 |
| Q4 2022 | 9,728 | 853 | -8.1% | $2.6M | 0.5% | $262.6 |
| Q3 2022 | 10,581 | 2,622 | -19.9% | $2.4M | 0.5% | $225.4 |
| Q2 2022 | 13,203 | 1,779 | -11.9% | $3.2M | 0.6% | $243.3 |
| Q1 2022 | 14,982 | +834 | +5.9% | $3.6M | 0.6% | $241.8 |
| Q4 2021 | 14,148 | +3,816 | +36.9% | $3.2M | 0.5% | $225.0 |
| Q3 2021 | 10,332 | +1,272 | +14.0% | $2.2M | 0.3% | $212.6 |
| Q2 2021 | 9,060 | +644 | +7.7% | $2.2M | 0.3% | $243.7 |
| Q1 2021 | 8,416 | +356 | +4.4% | $2.1M | 0.3% | $248.8 |
| Q4 2020 | 8,060 | +1,026 | +14.6% | $1.9M | 0.3% | $229.9 |
| Q3 2020 | 7,034 | +49 | +0.7% | $1.8M | 0.3% | $254.2 |
| Q2 2020 | 6,985 | 1,497 | -17.6% | $1.6M | 0.3% | $235.8 |
| Q1 2020 | 8,482 | 3,282 | -27.9% | $1.7M | 0.4% | $202.8 |
| Q4 2019 | 11,764 | 281 | -2.3% | $2.8M | 0.5% | $241.1 |
| Q3 2019 | 12,045 | +43 | +0.4% | $2.3M | 0.3% | $193.5 |
| Q2 2019 | 12,002 | +1,596 | +15.3% | $2.2M | 0.2% | $184.3 |
| Q1 2019 | 10,406 | +501 | +5.1% | $2.0M | 0.2% | $190.0 |
| Q4 2018 | 9,905 | 1,736 | -14.9% | $1.9M | 0.2% | $194.6 |
| Q3 2018 | 11,641 | +892 | +8.3% | $2.4M | 0.2% | $207.3 |
| Q2 2018 | 10,749 | +1,579 | +17.2% | $2.0M | 0.2% | $184.6 |
| Q1 2018 | 9,170 | +854 | +10.3% | $1.6M | 0.2% | $170.4 |
| Q4 2017 | 8,316 | +2,673 | +47.4% | $1.4M | 0.1% | $173.9 |
| Q3 2017 | 5,643 | — | — | $1.1M | 0.1% | $186.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did TORRAY INVESTMENT PARTNERS LLC first disclose a AMGN position in 13F-HR filings?
TORRAY INVESTMENT PARTNERS LLC first reported AMGEN (AMGN) on its 13F-HR filing for the period ending 2017-09-30 (Q3 2017). The position has appeared on 36 reported quarters within Pactolio's tracked window.
What was TORRAY INVESTMENT PARTNERS LLC's most recent quarter-over-quarter share-count change in AMGN?
Between Q1 2026 and Q2 2026, TORRAY INVESTMENT PARTNERS LLC added 5,759 shares of AMGN (+10.7%), bringing the total reported position to 59,771 shares at a market value of $21.6M.
Does the implied price-per-share represent TORRAY INVESTMENT PARTNERS LLC's cost basis in AMGN?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.